Skip to main content
Clinical Trials/NCT03533062
NCT03533062CompletedNot Applicable

Trigonal-sparing Versus Trigonal-involved Intravesical Botulinumtoxin A Injection in Refractory Idiopathic Detrusor Overactivity.

Mansoura University0 sites80 target enrollmentStarted: June 14, 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
80
Primary Endpoint
efficacy of Botox injections of the bladder treating OAB using Over active bladder Symptoms score (OABSS).OABSS total score is 15.more score means more symptoms.it is divided into:1-5 &6-10&11-15 means mild &moderate&sever symptoms respectively.

Study Overview

Brief Summary

The investigators attend to conduct a prospective randomized study to assess safety and efficacy of trigonal-involved vs. trigonal-sparing botox injection technique, quality of life measurement and post-injection anticholinergics use efficacy.

Assessing safety by identification of side effects like constipation, urine retention....etc.

efficacy is measured using Over Active Bladder Symptoms Score(OABSS) and urodynamics measures after 6 months follow up.

Detailed Description

Overactive bladder (OAB) is a condition characterized by the presence of urinary urgency, typically joined by frequency and nocturia, with or without urgency urinary incontinence [UUI], in the absence of urinary tract infection (UTI) or other clear pathology.

Frequency is the most commonly reported symptom coming to 85% while 54% complained of urgency and 36% urgency incontinence.

OAB has usually resulted from detrusor over activities. The basic cause could be a neurological disorder (neurogenic type) such as spinal cord injuries, multiple sclerosis. In some cases, no obvious cause could be identified (idiopathic type).

OAB is a prevalent, chronic symptom complex that can impair quality of life (QOL). The prevalence of OAB in the general population was evaluated at 11.8% in a population-based survey conducted across five European countries. Epidemiological studies from North America have reported prevalence of OAB in women of 16.9% and the prevalence increases with age rising to 30.9% in those beyond 65 years.

Treatment objectives are to reduce the occurrence of bothersome symptoms. Several treatment choices are available for OAB including bladder and behavioral training, pharmacologic treatment, and surgical treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with idiopathic OAB refractory to treatment with antimuscarinics for 2 months or intolerable side effects of antimuscrinics

Exclusion Criteria

  • Patients who have any of the following were excluded:
  • Age less than 18 year old.
  • Neurogenic detrusor overactivity.
  • Evidence of obstructed flow in absence of prolapse.
  • Mixed urinary incontinence
  • Associated urethral pathology, e.g. Urethral diverticulum
  • Associated bladder pathology e.g. Fistula.
  • Active urinary tract infection as evidenced by positive urine culture.

Arms & Interventions

trigonal sparing botox injection

Active Comparator

Using a 7 gauge needle injection were allocated uniformly and evenly throughout the designed area excluding trigone in other arm Dilution of BOTOX vial (100 u) in 10 ml normal saline (10 u/ml) and injected in 20 sites (0.5ml /site).•then after 6 months postoperative anticholinergics administration .

Intervention: botulinum toxin A (Drug)

trigonal involved

Active Comparator

Using a 7 gauge needle injection were allocated uniformly and evenly throughout the designed area including the trigone .Dilution of BOTOX vial (100 u) in 10 ml normal saline (10 u/ml) and injected in 20 sites (0.5ml /site).then after 6 months postoperative anticholinergics administration .

Intervention: botulinum toxin A (Drug)

Outcomes

Primary Outcomes

efficacy of Botox injections of the bladder treating OAB using Over active bladder Symptoms score (OABSS).OABSS total score is 15.more score means more symptoms.it is divided into:1-5 &6-10&11-15 means mild &moderate&sever symptoms respectively.

Time Frame: 3 months

Over active bladder symptoms score (OABSS).

Secondary Outcomes

  • Arabic validation of overactive bladder symptoms score(3 months)
  • efficacy of anticholinergics post botox injection using Over active bladder symptoms score (OABSS).(3 months)
  • quality of life assessment of patients with anticholinergics alone vs patients with botox injections vs combined therapy.(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohamed Abdelbaset

principal investigator

Mansoura University

Similar Trials